Pivotal Research Downgrades Balchem (BCPC) to Hold
Tweet Send to a Friend
Pivotal Research analyst Timothy Ramey downgraded Balchem (NASDAQ: BCPC) from Buy to Hold with a price target of $100.00.The analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


